This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Centre International De Recherches Dermatologigues Galderma (Cird. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Introduction
Marie-Cecile Lenoir is an innovative inventor based in Valbonne, France. With a passion for advancing dermatological solutions, she has made significant contributions to the field with her pioneering work on skin substitutes.
Latest Patents
Marie-Cecile Lenoir holds one notable patent, which focuses on a skin substitute composed of a dermis equivalent covered with an epidermis equivalent. This groundbreaking invention includes a dermis equivalent created from a type I collagen gel that contains fibroblasts. Additionally, the epidermis equivalent incorporates a basal membrane equivalent, with basal layer cells arranged in a palisade configuration. These cells are attached to the membrane through hemidesmosomes, and the structure is further enhanced with cells from the suprabasal layers, granular cells, and flat, keratinized cells located near the free surface.
Career Highlights
Throughout her career, Marie-Cecile has been dedicated to improving dermatological practices and outcomes. Her expertise in skin substitutes showcases her commitment to finding solutions for skin-related issues, which can greatly benefit patients experiencing various dermatological conditions.
Collaborations
Marie-Cecile Lenoir collaborates with esteemed colleagues in the field, including Bruno Bernard and Braham Shroot. Together, they contribute to research and development initiatives that push the boundaries of current dermatological treatments and innovations.
Conclusion
In conclusion, Marie-Cecile Lenoir is a remarkable inventor whose work on skin substitutes holds promise for numerous applications in dermatology. Her dedication to innovation and collaboration with fellow professionals underscores her significant role in advancing medical technology and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile